Secondary analysis pooling two sham-controlled accelerated iTBS trials in 104 patients with treatment-resistant depression: higher baseline novelty seeking was linked to faster one-week improvement in both arms, but this exploratory link did not survive multiplicity correction.
Secondary analysisn = 104
Chiarenza et al. Novelty seeking and rapid symptom improvement across active and sham accelerated iTBS conditions: A pooled individual-patient data analysis